Searchable abstracts of presentations at key conferences in endocrinology

ea0049ep116 | Clinical case reports - Pituitary/Adrenal | ECE2017

Primary hyperparathyroidism and primary hyperaldosteronism – cause or coincidence in arterial hypertension – case report

Icin Tijana , Bajkin Ivana , Tomic Dusan , Novakovic-Paro Jovanka , Vukovic Bojan , Prodanovic Jovana , Medic-Stojanoska Milica

Introduction: 30% of the adult population has high blood pressure. About 6% of the hypertension may be caused by primary aldosteronism and very rare by primary hyperparathyroidism. The combination of these two causes is very rare.Case report: Our patient is women (age 50) with a 21 year long history of uncontrolled hypertension. Treatment of hypertension consist of a beta-blocker, calcium channel blockers, angiotensin converting enzyme inhibitor, loop di...

ea0035p94 | Bone and Osteoporosis | ECE2014

Influence of osteoporosis risk factors on extensive suppression of bone metabolism during antiresorptive therapy

Icin Tijana , Novakovic-Paro Jovanka , Vukovic Bojan , Bajkin Ivana , Medic-Stojanoska Milica

Introduction: Some patients develop excessive bone metabolism supression during antiresorptive therapy. Low remodelling rate enables increase in tissue mineralisation density and homogenicity of bone trabeculae. Increase in density makes micro-damage more likely. Increased homogenicity provides less resistance to spread of the micro-cracks and slowed remodelling slows down removal of microdemage. All this leads to increased bone fragility.Aim: To establi...

ea0022p88 | Bone/Calcium | ECE2010

Vitamin D and calcium status in women with postmenopausal osteoporosis

Novakovic-Paro Jovanka , Kovacev-Zavisic Branka , Medic-Stojanoska Milica , Bajkin Ivana , Icin Tijana , Todorovic-Djilas Ljiljana

Many studies show insufficient and inadequate vitamin D and calcium levels in postmenopausal women with osteoporosis, thus emphasising the need for supplementation therapy.Aim of the study: To determine vitamin D (25(OH)D) and ionised calcium levels in women treated for postmenopausal osteoporosis at our Clinic in the course of year 2009.Materials and methods: We prospectively followed up 116 women at the age of 59.38±5.55 (mi...

ea0022p219 | Clinical case reports and clinical practice | ECE2010

Secondary osteoporosis and secondary hyperparathyroidism in patient with Hashimoto thyroiditis and coeliac disease (case report)

Icin Tijana , Kovacev-Zavisic Branka , Novakovic-Paro Jovanka , Bajkin Ivana , Medic-Stojanoska Milica , Todorovic-Djilas Ljiljana

Introduction: Autoimmune thyroid disease is often associated with other autoimmune diseases. Coeliac disease is one of those autoimmune diseases, together with is wide spectrum of intestinal and extraintestinal manifestations. Atrophy of intestinal mucosa, one of the characteristics of coeliac disease, among everything else, leads to poor absorption of l-tyroxine used in therapy of hypothyroidism.Aim and results: We like to present a clinical case of our...

ea0020p263 | Bone/Calcium | ECE2009

Bone resorption and antiresorptive effect of bisphosphonates related to homocysteinaemia

Icin Tijana , Kovacev-Zavisic Branka , Medic-Stojanoska Milica , Cabarkapa Velibor , Novakovic-Paro Jovanka , Bajkin Ivana

Introduction: Some recent data indicates that high levels of homocysteine (Hcy) can be independent risk factor for osteoporosis and fractures in elderly. There are few explanations how homocysteine influence bone resorption and probably modify effect of therapy for osteoporosis. 1. Hcy interferes with collagen cross-linking. 2. High levels of Hcy specially stimulate resorptive activity of osteoclasts in vitro. 3. Hcy interfere bisphosphonates binding to hydroxyapatite.<...

ea0049ep709 | Obesity | ECE2017

Prevalence of mono-ethyl-hexyl phthalate and mono-ethyl phthalate in Serbian population and their influence on leptin and thyroid function in obesity

Bajkin Ivana , Milic Natasa , Novakovic-Paro Jovanka , Icin Tijana , Prodanovic Jovana , Curic Nikola , Vukovic Bojan , Medic-Stojanoska Milica

Introduction: Phthalates are ubiquitous endocrine disruptors (EDs). EDs induce obesity. MEP and MEHP affect thyroid function.Aim: Estimation of burden of MEP and MEHP in our population, evaluation of leptin in obese MEP and MEHP positive and negative subjects and evaluation of connection between leptin, MEP, MEHP and thyroid indicators in that subgroup. Materials and methods: a cross-sectional study, with 201 subjects divided into MEP/MEHP positive and n...

ea0049ep1024 | Pituitary - Clinical | ECE2017

Etiology and some clinical characteristics of hypopituitarism over the years of follow up

Stojanoska Milica Medic , Vukovic Bojan , Bajkin Ivana , Icin Tijana , Milankov Andrijana , Novakovic Paro Jovanka , Prodanovic Jovana , Curic Nikola

The data of etiology and clinical characteristics of hypopituitarism in different countries differes. The aim of the study is to investigate etiology and some clinical characteristics of patients with hypopituitarism that were treated in the Clinical center of Vojvodina. The study was conducted as a retrospective study. There were 32 males and 28 female patients. Mean age was 52.2±17.5 years. Data was analized before and after substitution of hypopituitarism. Patients wer...

ea0037ep238 | Calcium and Vitamin D metabolism | ECE2015

Effect of supplementation with vitamin D and calcium to excessive suppression of bone metabolism during antiresorptive therapy

Icin Tijana , Kovacev-Zavisic Branka , Novakovic-Paro Jovanka , Bajkin Ivana , Vukovic Bojan , Percic Ivanka , Kovacev Nemanja , Medic-Stojanoska Milica

Introduction: Long-term therapy with bisphosphonates is considered a risk factor for the development of atypical fractures of the femur. One of the mechanisms of these fractures is excessive suppression of bone metabolism. The supplementation dose of vitamin D and calcium could have an impact on the degree of suppression of bone turnover.The aim: To determine whether the presence or dose of supplementation with vitamin D and calcium during antiresorptive...

ea0037ep782 | Pituitary: clinical | ECE2015

Some clinical characteristics and cardiovascular risk of our patients with hypopituitarism during long-time follow-up

Medic-Stojanoska Milica , Milankov Andrijana , Vukovic Bojan , Icin Tijana , Bajkin Ivana , Novakovic-Paro Jovanka , Percic Ivanka , Kovacev-Zavisic Branka

Several studies have pointed to increased morbidity and mortality in patients with hypopituitarism, particularly from cardiovascular diseases, regardless of the application of the substitution therapy. The aim of this study was to present clinical characteristics and cardiovascular risk of our patients with hypopituitarism during 20 years of follow-up.Methods: Sixty patients with hypopituitarism without patients with acromegaly and Cushing disease were a...

ea0026p531 | Bone/calcium/Vitamin D | ECE2011

Restitution of sever bone changes after succsessful treatment of primary hyperparathyroidism

Novakovic-Paro Jovanka , Kovacev-Zavisic Branka , Icin Tijana , Bajkin Ivana , Popovic Djordje , Vukovic Bojan , Mitrovic Milena , Medic-Stojanoska Milica

Primary hyperparathyroidism is an autonomous form of hyperparathyroidism, whose characteristics are: increased secretion of parathyroid hormone with clinical signs of hypercalcemic syndrome and various organ lesions, including bones.Case report: A 51-year-old Caucasian female presented with walking difficulties, polyuria, polydipsia, palpitations and headaches. Examination showed thoracic spine hyperkyphosis with consecutive chest deformity, staggered wa...